Chewable Pimobendan Tablet Matches Commercial Formulation in Beagle Dog Study
A newly developed pimobendan chewable tablet demonstrated dissolution and pharmacokinetic profiles comparable to an existing commercial formulation in beagle dogs.
A newly developed pimobendan chewable tablet demonstrated dissolution and pharmacokinetic profiles comparable to an existing commercial formulation in beagle dogs.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.